Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial.

Terada KY, Ahn HJ, Kessel B. Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial. J Gynecol Oncol. 2016 May; 27(3):e25.

View in: PubMed

authors with profiles

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support